Sangamo BioSciences to Webcast Annual Investor and Analyst Briefing and Presentation at Piper Jaffray Health Care ...(nsequently cellfunction. Sangamo is als...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Sangamo BioSciences to Webcast Annual Investor and Analyst Briefing and Presentation at Piper Jaffray Health Care Conference
Date:11/25/2008
nsequently, cell function. Sangamo is also developing sequence-specific ZFP Nucleases (ZFN(TM)) for gene modification. Sangamo has established strategic partnerships with companies outside of the human therapeutic space including Dow AgroSciences, Sigma-Aldrich Corporation and several companies applying its ZFP technology to enhance the production of protein pharmaceuticals. For more information about Sangamo, visit the company's web site at http://www.sangamo.com.
This press release may contain forward-looking statements based on Sangamo's current expectations. These forward-looking statements include, without limitation, references to the research and development of novel ZFP TFs and ZFNs as ZFP Therapeutics, applications of Sangamo's ZFP TF technology platform, strategic partnerships with collaborators and clinical trials of ZFP Therapeutics. Actual results may differ materially from these forward-looking statements due to a number of factors, including technological challenges, uncertainties relating to the initiation and completion of stages of ZFP Therapeutic clinical trials, Sangamo's ability to develop commercially viable products and technological developments by our competitors. See the company's SEC filings, and in particular, the risk factors described in the company's Annual Report on Form 10-K and its most recent Quarterly Report on Form 10-Q. Sangamo BioSciences, Inc. assumes no obligation to update the forward-looking information contained in this press release.
'/>"/>
| SOURCE Sangamo BioSciences, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
2. Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
3. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
4. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
5. Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
6. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
7. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
8. Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
9. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
10. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
11. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
Post Your Comments:
Breaking Biology Technology:Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 2Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 3Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 4Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 5Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 6Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 7Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 8Vivakor Announces Mechanics of Dividend Distribution 2Vivakor Announces Mechanics of Dividend Distribution 3HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia 2HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia 3New technology could boost disease detection tests' speed and sensitivity 2
[0] Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective[0] Vivakor Announces Mechanics of Dividend Distribution[0] HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia[0] New technology could boost disease detection tests' speed and sensitivity
Other Biology Technology:Mach One Executes Definitive Agreement to Acquire Biopharmaceutical Design & Engineering Firm 2Zeus Announces Product Name Changes 2Dow AgroSciences Delivering Beyond Expectations 2Dow AgroSciences Delivering Beyond Expectations 3
Breaking Biology News(10 mins):Spices halt growth of breast stem cells, U-M study finds 2Researchers demonstrate nanoscale X-ray imaging of bacterial cells 2New York autopsies show 2009 H1N1 influenza virus damages entire airway 2New York autopsies show 2009 H1N1 influenza virus damages entire airway 3Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference 5367 1Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference 5367 2HPV Tied to Rare Head and Neck Cancer 59233 1HPV Tied to Rare Head and Neck Cancer 59233 2Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 1Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 2Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |